title: [Adverse effects of hypolipemic drugs: how to treat in clinical practice].
abstract: Hypolipemic drugs improve coronary morbidity and mortality and appear to be safe; nevertheless appropriate monitoring is recommended. Adverse effects are reported that are frequently transitory. Severe adverse effects are infrequent, but clinicians must correctly screen them; symptoms and laboratory changes must be carefully interpreted. Often they call for special treatment and replacement of the hypolipemic drugs in use. This article emphasizes how to treat dyslipidemia if skeletal muscle and liver involvement are present. Briefly other adverse effects are also reported.
authors: Instituto do Coração, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP.
authors: Neusa
authors: N
authors: Forti
authors: Jayme
authors: J
authors: Diament
mesh_terms: D056486:Chemical and Drug Induced Liver Injury; D002986:Clinical Trials as Topic; D004798:Enzymes / Q000187:drug effects; D006801:Humans; D000960:Hypolipidemic Agents / Q000009:adverse effects*; D009135:Muscular Diseases / Q000139:chemically induced*
chemical_list: D004798:Enzymes; D000960:Hypolipidemic Agents